NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) announced today the final results of its offer to purchase for cash up to $15 million of its shares of common stock, $0.001 par value, at a fixed price of $9.43 per share (the “Tender Offer”). The Tender Offer expired at 5:00 p.m., New York City time, on February 2, 2026 (the “Expiration Time”). The Tender Offer was oversubscribed. In accordance with the terms and conditions of the Tender Off ...

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) announced today the preliminary results of its offer to purchase for cash up to $15 million of its shares of common stock, $0.001 par value, at a fixed price of $9.43 per share (the “Tender Offer”). The Tender Offer expired at 5:00 p.m., New York City time, on February 2, 2026 (the “Expiration Time”). The Tender Offer was oversubscribed. In accordance with the terms and conditions of the Tend ...

Financial Disclosure Calendar - Iveco Group has announced its financial disclosure calendar for 2026, which includes key earnings release dates [2] - The earnings releases are scheduled for 12 February (Q4 2025 and preliminary annual results), 7 May (Q1 2026), 30 July (Q2 2026), and 5 November (Q3 2026) [2] Annual General Meeting - The Annual General Meeting to discuss and approve the Full Year Financial Statements is expected to take place in early June 2026 [4] - No ordinary annual cash dividend distribution is foreseen for FY2025 [4] Defence Business Separation - The corporate carve-out of the Defence Business (IDV and ASTRA brands) was completed in 2025, with regulatory approval processes ongoing [5] - An Extraordinary General Meeting to authorize the distribution of net proceeds from the sale of the Defence Business to Leonardo S.p.A. is expected in the second half of March 2026 [5] - The estimated extraordinary dividend remains between €5.5 and €6.0 per share, with payment anticipated in April 2026 [5] Spin-off Plans - If the sale to Leonardo S.p.A. is not completed by 31 March 2026, the company plans to complete a spin-off of the Defence Business through a statutory demerger [6] - The demerger proposal will be voted on at the Defence EGM as a precautionary measure [6] Tender Offer - A voluntary tender offer for issued common shares post-defence separation is expected to complete in the first half of 2026 [7] - The tender offer is conditional upon the separation of the Defence Business, with EGMs for Defence and the Tata Motors tender offer expected in March and early May 2026, respectively [7] Financial Performance - Preliminary and unaudited figures for Q4 and FY 2025 will be presented on 12 February 2026 [10] - The company anticipates that all financial targets will be met or slightly below guidance, except for Industrial Free Cash Flow, which is estimated at about €60 million, significantly below the previous guidance of €250 million - €350 million [11]

NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Total Return Securities Fund (NYSE: SWZ) (f/k/a The Swiss Helvetia Fund) (the “Fund”) announced today that its tender offer to purchase up to 4 million of the Fund’s shares for cash expired at 5:00 p.m., New York City time, on January 20, 2026. Based on information provided by Equiniti Trust Company, LLC, the depositary for the tender offer, a total of 12,035,603.471 shares were validly tendered. As more than 4 million shares were validly tendered, the number of s ...

Core Viewpoint - Lisata Therapeutics, Inc. has entered into a binding term sheet for acquisition by Kuva Labs, Inc., with a cash offer of $4.00 per share, representing an approximate 85% premium over Lisata's recent closing stock price [1][2] Group 1: Acquisition Details - Kuva will commence a tender offer to purchase all outstanding shares of Lisata at $4.00 per share in cash [1] - Stockholders will receive two contingent value rights (CVRs) valued at $1 each, contingent upon specific milestones related to the drug certepetide [1][2] - The acquisition has been unanimously approved by the boards of directors of both companies, with a definitive purchase agreement expected before February 27, 2026 [1] Group 2: Product Information - Certepetide is an investigational drug designed to enhance the delivery of anti-cancer therapies to solid tumors, showing favorable safety and clinical activity in trials for pancreatic cancer [4][5] - The drug has received multiple designations, including Fast Track and Orphan Drug Designation for various cancers, indicating its potential in treating serious diseases [4][5] Group 3: Company Background - Lisata Therapeutics focuses on developing innovative therapies for advanced solid tumors and has established partnerships based on its CendR Platform technology [5] - Kuva Labs is a preclinical bioscience company developing the NanoMark direct MR imaging platform, aimed at improving cancer detection and treatment [7]

Core Viewpoint - Crédit Agricole Assurances successfully completed its Tender Offer for two series of subordinated fixed rate resettable notes, with a total valid tender amount of €861,400,000 [1][5]. Group 1: Tender Offer Details - The Tender Offer was launched on January 8, 2026, targeting subordinated fixed rate resettable notes issued in 2016 and 2018, with an outstanding principal amount of €1,000 million each [2]. - The Tender Offer expired on January 15, 2026, at 4:00 p.m. Central European Time, and no notes tendered after this time were accepted [3]. - The final acceptance amount for the Tender Offer was set at €749,900,000, with €221,900,000 for the 4.75% notes and €528,000,000 for the 2.625% notes [5]. Group 2: Financial Implications - The Tender Offer will allow Crédit Agricole Assurances to spread the maturity profile of its debt, aligning with its active capital management policy [2]. - Holders of the validly tendered notes will receive cash equal to the tender price multiplied by the aggregate principal amount of the notes accepted for purchase, plus accrued interest [6]. - The settlement of the Tender Offer is expected to occur on January 20, 2026, with payments processed through Euroclear, Clearstream, or Euroclear France [7]. Group 3: Cancellation of Notes - The existing notes that were validly tendered and accepted will be cancelled immediately following the settlement of the Tender Offer [8].

Core Viewpoint - Terrafina, a leading Mexican industrial real estate investment trust (FIBRA), has completed its cash tender offer for its outstanding 4.962% Notes due 2029, which expired on January 12, 2026 [1][2]. Group 1: Tender Offer Details - The tender offer was initiated on January 6, 2026, and allowed holders to tender their 4.962% Senior Notes due 2029 [2]. - A total of U.S.$439,452,000 of the Notes were validly tendered and not withdrawn by the expiration date, with an additional U.S.$2,203,000 received under guaranteed delivery procedures [2]. - Terrafina will pay the tender offer consideration plus accrued interest on January 15, 2026, for all validly tendered Notes [3]. Group 2: Company Overview - Terrafina (BMV: TERRA13) is focused on acquiring, developing, leasing, and managing industrial real estate properties in Mexico, with a portfolio of strategically located warehouses and light manufacturing properties [6].

Core Viewpoint - Terrafina, a leading Mexican industrial real estate investment trust (FIBRA), has initiated a cash tender offer for its outstanding 4.962% Senior Notes due 2029, aiming to retire and potentially redeem these notes in the future [1][2]. Tender Offer Details - The tender offer is for all outstanding 4.962% Senior Notes due 2029, with a total principal amount of U.S.$500 million, offering a consideration of U.S.$1,028.95 per U.S.$1,000 principal amount [2]. - The expiration date for the tender offer is set for January 12, 2026, with the settlement date expected to occur three business days after this date [3]. - Holders of the notes can withdraw their tendered notes prior to the expiration date or within 10 business days if the offer is extended [4]. Conditions and Procedures - Completion of the tender offer is subject to certain conditions outlined in the offer documents, and Terrafina reserves the right to amend or terminate the offer at any time [6]. - Holders who utilize guaranteed delivery procedures must deliver their notes by January 14, 2026 [5]. Company Overview - Terrafina (BMV: TERRA13) focuses on acquiring, developing, leasing, and managing industrial real estate properties in Mexico, with a portfolio that includes strategically located warehouses and light manufacturing properties [11].

Core Viewpoint - Data Storage Corporation has announced an extension of the expiration date for its Offer to Purchase from January 7, 2026, to January 12, 2026, indicating ongoing efforts to complete the tender offer process [1]. Company Overview - Data Storage Corporation, through its subsidiary Nexxis, Inc., provides Voice over Internet Protocol (VoIP) and Unified Communications, along with dedicated internet connectivity as part of its comprehensive service offerings [2]. - The company plans to invest in various sectors post-tender offer completion, including GPU Infrastructure-as-a-Service (IaaS), AI-driven software applications, cybersecurity, and voice/data telecommunications, aiming to build sustainable and recurring revenue streams while maintaining financial discipline [2].

SpaceX Tender Offer Rockets Elon Musk Closer To Trillionaire Status https://t.co/6rHGsGBBtB ...